Abstract S17 Table 1

Odds ratios for the association between bronchiectasis and cardiovascular risk factors or commonly prescribe cardiovascular drugs

Cardiovascular risk factor or prescription of cardiovascular medicationNumber of people (%) (n = 3,895,800)Number without bronchiectasis (%) (n = 3,884,858)Number with bronchiectasis (%) (n = 10,942)Adjusted odds ratio* (95% CI)
Smoking statusNever smoker773,094 (19.8)768,975 (19.8)4119 (37.6)1.00
Ex-smoker296,223 (7.6)293,072 (7.5)3151 (28.8)1.30 (1.23–1.36)
Current smoker605,205 (15.5)601,533 (15.5)3672 (33.6)0.88 (0.84–0.92)
Missing data2,221,278 (57.0)2,221,278 (57.2)0-
HypertensionNo3,200,460 (82.1)3,193,289 (82.2)7171 (65.5)1.00
Yes695,340 (17.9)691,569 (17.8)3771 (34.5)0.94 (0.90–0.98)
HypercholesterolemiaNo3,643,743 (93.5)3,634,097 (93.5)9646 (88.2)1.00
Yes252,057 (6.5)250,761 (6.5)1296 (11.8)0.94 (0.89–0.98)
DiabetesNo3,708,873 (95.2)3,698,882 (95.2)9991 (91.3)1.00
Yes187,281 (4.8)186,330 (4.8)951 (8.7)0.97 (0.91–1.04)
Family history of cardiovascular diseaseNo3,104,934 (79.7)3,096,973 (79.7)7961 (92.8)1.00
Yes790,866 (20.3)787,885 (20.3)2981 (27.2)1.14 (1.07–1.19)
β blockersNo3,350,205 (86.0)3,339,303 (86.0)10,902 (99.6)1.00
Yes545,595 (14.0)545,555 (14.0)40 (0.4)0.02 (0..01–0.03)
Angiotensin converting enzyme (ACE) inhibitor or Angiotensin II receptor blockerNo3,448,012 (88.5)3,437,161 (88.5)10,860 (99.3)1.00
Yes447,770 (11.5)447,697 (11.5)82 (0.8)0.03 (0.02–0.04)
NitratesNo3,732,559 (95.8)3,772,786 (95.8)9773 (89.3)1.00
Yes163,241 (4.2)162,072 (4.2)1169 (10.7)1.29 (1.21–1.38)
Calcium channel blockersNo3,572,373 (91.7)3,563,365 (91.7)9008 (82.3)1.00
Yes323,427 (8.3)321,493 (8.3)1934 (17.7)1.02 (0.97–1.08)
Anti-plateletsNo3,446,225 (88.5)3,435,850 (88.4)10,375 (94.8)1.00
Yes449,575 (11.5)449,008 (11.6)567 (5.2)0.14 (0.13–0.15)
Lipid lowering drugsNo3,423,738 (87.9)3,413,209 (87.9)10,527 (96.2)1.00
Yes472,062 (12.1)471,649 (12.1)413 (3.8)0.11 (0.10–0.12)
  • *Odds ratios adjusted for age and sex